Explore the categories so you can find more about your search.
Categorie > Arthritis
ACTEMRA Significantly Improves Symptoms For Rheumatoid Arthritis Patients Who Did Not Respond Well To Standard Therapy
Categorie : ArthritisPatients with rheumatoid arthritis treated with ACTEMRA? (tocilizumab) experienced a rapid and significant reduction in the signs and symptoms of their disease, according to a study published in this week's issue of The Lancet. ...
read more 
Sat Apr 2008
Rheumatoid Arthritis Patients Benefit From Vegan, Gluten-free Diet
Categorie : ArthritisA gluten-free vegan diet may improve the health of patients with rheumatoid arthritis, according to new research from Karolinska Institutet. The diet has a beneficial effect on several risk factors for cardiovascular disease. Rheumatoid arthritis is associated with an increased risk of atheroscleros ...
read more Sat Apr 2008
What Causes Rheumatoid Arthritis - How Is Your Heart Affected?
Categorie : ArthritisIn a recent issue of The Johns Hopkins Arthritis Bulletin, Johns Hopkins specialists reported on the latest research regarding the link between rheumatoid arthritis and heart health. With rheumatoid arthritis, the inflammation that damages joints also takes a toll on the heart. Johns Hopkins special ...
read more Sat Apr 2008
ACZ885, A New Biological Drug In Development, Shows Potential In Treating Serious Life-long Autoinflammatory Diseases
Categorie : ArthritisNew data demonstrate that ACZ885, a human monoclonal antibody in Phase III development, achieves long-lasting clinical remission in patients with genetic autoinflammatory diseases1,2. The results indicate that ACZ885 could develop into a major therapeutic advance in the treatment of Cryopyrin-Associ ...
read more Sat Apr 2008
Hit Pain Where It Hurts: Arthritis Care Launches New UK Course
Categorie : ArthritisTime to take your life back - that's Arthritis Care's message to 7.8 million* people in the UK who live with chronic day-to-day pain. The 61-year old charity today marks its awareness week (12th-18th April) by launching its new Challenging Pain programme across the country.. Around half of those liv ...
read more Sat Apr 2008
Current And Emerging Drugs Have No Advantage Over Enbrel In Inhibiting/Slowing The Progression Of Rheumatoid Arthritis
Categorie : ArthritisDecision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that a drug's effect on inhibiting/slowing the progression of structural damage and reducing the signs and symptoms of rheumatoid arthritis during the first year of tr ...
read more Sat Apr 2008
Can-Fite: First Patient Was Enrolled To The Phase IIb Rheumatoid Arthritis Trial
Categorie : ArthritisCan-Fite BioPharma (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, reports that a confirmatory Phase IIb trial is now enrolling patients as part of the ongoing development of CF101. The regulatory process in which the Company was involved during the past few months result ...
read more Sat Apr 2008
Anti-Arthritis Drug Tocilizumab Effective In Adults And Children
Categorie : ArthritisTwo studies published in the March 22, 2008 issue of The Lancetindicate that the anti-arthritis drug tocilizumab can be effective inadults or children. Adult rheumatoid arthritis (RA) is an autoimmune inflammatory diseaseaffecting the patient systemically. It is associated with progressivejoint dama ...
read more Sat Apr 2008
Cod Liver Oil Reduces Painkiller Use
Categorie : Arthritis"Two teaspoons of cod liver oil a day can cut the number of powerful painkillers needed to ease the pain of arthritis", reports the Daily Mail. Patients who were given the supplements "were able to reduce their daily dose of anti-inflammatory drugs", the newspaper says. These findings are important ...
read more Sat Apr 2008
Neurochem Withdraws Its Marketing Authorisation Application For Kiacta(eprodisate Disodium), Europe
Categorie : ArthritisThe European Medicines Agency (EMEA) has been formally notified byNeurochem Luxco II SARL of its decision to withdraw the application fora centralised marketing authorisation for the medicine Kiacta(eprodisate disodium) capsules.Kiacta was expected to be used for the treatment of amyloid Aamyloidosi ...
read more Sat Apr 2008
Amgen And Wyeth Announce Updates To U.S. Prescribing Information For Enbrel(R)
Categorie : ArthritisAmgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced updates to the U.S. Food and Drug Administration (FDA)-approved U.S. Prescribing Information (PI) for Enbrel(R) (etanercept). The U.S. PI now contains a boxed warning relating to the risk of infections, in ...
read more Sat Apr 2008
International ACTEMRA Rheumatoid Arthritis Study Highlighted In The Lancet
Categorie : ArthritisPatients with rheumatoid arthritis treated with Roche's ACTEMRA(TM) (tocilizumab) experienced significant and rapid reduction in the signs and symptoms of their disease, according to a study published in this week's issue of The Lancet. ...
read more Sat Apr 2008
Major Boost For Primary Care Research At Keele University As National Arthritis Charity Awards 2.5m Pounds Funding, UK
Categorie : ArthritisA major new centre promoting research into primary care has been created at Keele University with funding of £2.5m over five years from a leading arthritis charity. The Arthritis Research Campaign National Primary Care Centre at Keele will have a direct benefit on the thousands of people in the UK ...
read more Sat Apr 2008
Decline In Work Disability Due To Rheumatoid Arthritis
Categorie : ArthritisRheumatoid arthritis (RA) is a chronic inflammatory disease affecting the joints and, in severe cases, vital organs. Marked by pain, fatigue, and loss of dexterity and mobility, RA has been strongly associated with work disability in the US. In previous studies of patients with advanced RA, 10 years ...
read more Sat Apr 2008
Increase Of Hip And Knee Replacements In The U.S.
Categorie : ArthritisWith the graying of America's Baby Boomer generation, arthritis is a growing health concern. Traditionally associated with the elderly, this common joint disease currently afflicts over 20 million men and women in the United States. To aggravate matters, arthritis is also prevalent among the overwei ...
read more Sat Apr 2008
Cartilage Repair Hope Offered By Stem Cells Tor Arthritis Sufferers
Categorie : ArthritisResearch presented at the UK National Stem Cell Network Annual Science Meeting in Edinburgh could offer hope that bone stem cells may be harnessed to repair the damaged cartilage that is one of the main symptoms of osteoarthritis. ...
read more Sat Apr 2008
Physical Activity Is Natural Pain Reliever For Arthritis
Categorie : ArthritisIt may seem counterintuitive to exercise when suffering with joint pain, but physical activity is actually a natural pain reliever for most people suffering from arthritis. A recent study published in Arthritis Care and Research journal concluded that regular exercise, specifically the Arthritis Fou ...
read more Sat Apr 2008
FDA Approves Orencia(R) (abatacept) For Moderate-To-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) In Patients Over Six
Categorie : ArthritisBristol-Myers Squibb Company (NYSE: BMY)today announced that the U.S. Food and Drug Administration (FDA) has approved ORENCIA® (abatacept) for reducing signs and symptoms in pediatric patients six years and older with moderately to severely active polyarticular juvenile idiopathic arthritis (JIA). O ...
read more Sat Apr 2008
Man Hypnotizes Himself And Has Bone-cutting Thumb Operation Without Anesthetic
Categorie : ArthritisDoctors were amazed when Alex Lenkei, a professional hypnotist, underwent a thumb operation which required sawing and chiseling of a bone without any anesthetic - and he said he did not feel a thing during the 80-minute operation at Worthing and Southlands Hospital, West Sussex, England. Lenkei need ...
read more Sat Apr 2008
Mesoblast Limited Announce Long-Lasting And Sustained Effect By Allogeneic Cells In Knee Osteoarthritis Preclinical Trials
Categorie : ArthritisAustralia's adult stem cell company, Mesoblast Limited (ASX: MSB; USOTC: MBLTY), announced successful long-term results in its osteoarthritis preclinical trials. A single injection of its proprietary allogeneic, or "off-the-shelf", adult stem cells into arthritic knees provided sustained protection ...
read more Sat Apr 2008
